Suggested Topics within your search.
Suggested Topics within your search.
- Biochemistry 2
- Chemistry, Clinical 2
- Health and Fitness 2
- methods 2
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Contraception 1
- Endocrine System Diseases 1
- Endocrine aspects 1
- Endocrine gynecology 1
- Genital Diseases, Female 1
- Health and Wellbeing 1
- Infertility 1
- Infertility, Female 1
- Physiological Phenomena 1
- Reproductive Techniques, Assisted 1
- endocrine glands 1
-
2561
Leptin levels in obese women with and without type 2 diabetes mellitus
Published 2004-01-01“…INTRODUCTION: The role of leptin has been more clear in the endocrinology area after the discovery of its secretion from the adipose tissue. …”
Get full text
Article -
2562
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Published 2015-01-01Get full text
Article -
2563
Comparison of fracture risk calculators in elderly fallers: a hospital-based cross-sectional study
Published 2022-07-01Get full text
Article -
2564
-
2565
-
2566
-
2567
-
2568
-
2569
Relationship Between Serum HMGB1 and RAGE Levels and Restenosis in Type 2 Diabetes Mellitus Patients Complicated With Lower Extremity Vascular Disease: A Retrospective Study
Published 2025-02-01“…Ting Jia,* Xuyan Zhang,* Li Li, Xiaowan Jiang, Mengjie Wang Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xuyan Zhang, Department of endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China, Tel +86 027 65696337, Email Zhangxuuyan21@163.comPurpose: To investigate the potential association between the serum concentrations of high mobility group protein B1 (HMGB1) and the receptor for advanced glycation end-products (RAGE) in relation to the occurrence of restenosis following interventional therapy for lower extremity vascular disease in patients diagnosed with type 2 diabetes mellitus (T2DM).Patients and Methods: From March 2023 to January 2024, 96 T2DM patients with lower extremity vascular disease who underwent interventional therapy and 6-month follow-up in our hospital were studied. …”
Get full text
Article -
2570
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease
Published 2025-01-01Get full text
Article -
2571
-
2572
-
2573
-
2574
Crowned dens syndrome: A case series of 72 patients at eight teaching hospitals in Japan
Published 2023-05-01Get full text
Article -
2575
-
2576
Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients
Published 2021-01-01Get full text
Article -
2577
Clinical Chemistry : fundamentals and laboratory techniques /
Published 2017Table of Contents: “…Boosalis and Jean Brickell -- Endocrine disorders and function / Wendy Arneson, Karen Chandler, and Jean Brickell -- Reproductive endocrinology and fetal testing / Wendy Arneson and Jean Brickell -- Malignancy disorders and testing / Michelle Kanuth, Camellia St. …”
Table of contents only
View in OPAC
Book -
2578
Coexistence of Ankylosing Spondylitis and Klinefelter's Syndrome
Published 2013-01-01Get full text
Article -
2579
Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic
Published 2012-01-01Get full text
Article -
2580
Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
Published 2020-01-01“…Following control of thyroid status by the Endocrinology team, this recurred after recommencement of ustekinumab on two further occasions over a 5-year period. …”
Get full text
Article